BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10919663)

  • 1. Deletion at 13q21 is associated with aggressive prostate cancers.
    Dong JT; Chen C; Stultz BG; Isaacs JT; Frierson HF
    Cancer Res; 2000 Jul; 60(14):3880-3. PubMed ID: 10919663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
    Chen C; Bhalala HV; Vessella RL; Dong JT
    Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
    Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
    Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
    Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
    Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
    Prasad MA; Trybus TM; Wojno KJ; Macoska JA
    Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of proximal 6q deletions in prostate cancer.
    Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
    Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xq27-28 deletions in prostate carcinoma.
    Kibel AS; Faith DA; Bova GS; Isaacs WB
    Genes Chromosomes Cancer; 2003 Aug; 37(4):381-8. PubMed ID: 12800149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
    Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
    Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer.
    Chen C; Bhalala HV; Qiao H; Dong JT
    Oncogene; 2002 Sep; 21(43):6567-72. PubMed ID: 12242654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping at 12p12-13 in metastatic prostate cancer.
    Kibel AS; Freije D; Isaacs WB; Bova GS
    Genes Chromosomes Cancer; 1999 Jul; 25(3):270-6. PubMed ID: 10379873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P; Kyllönen AP; Nordling S; Vihko P
    Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers.
    Fukuhara H; Maruyama T; Nomura S; Oshimura M; Kitamura T; Sekiya T; Murakami Y
    Oncogene; 2001 Jan; 20(3):314-9. PubMed ID: 11313960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
    Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
    Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
    Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
    Oncogene; 1998 Jan; 16(4):481-7. PubMed ID: 9484837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.